US$ 24.11
glp 1 agonist pharmacology Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Increased Na+/H+-Exchange Activity Is the Cause of Increased [Na+]i and Underlies Disturbed Calcium Handling in the Rabbit Pressure and Volume Overload Heart Failure Model

Underlying medical conditions and concurrent medications can significantly impact the effectiveness of weight loss injections, sometimes creating physiological barriers to expected outcomes

doi: 10.1186/1472-6793-11-12 54 YamadaCYamadaYTsukiyamaKYamadaKUdagawaNTakahashiNet al

Mechanisms and Pathways of Anti-Inflammatory Activity of DPP-4 Inhibitors in Cardiovascular and Renal Protection

But clinicians are also noting mood changes, flattened affect, and potential links to depression in patients with dopamine-related vulnerabilities

Click here to read the Digest.
